Ronald D. Alvarez, MD
Professor
University of Alabama at Birmingham
Division of Gynecologic Oncology
619 19th St S
Birmingham,
AL
USA
35249
Papers:
39
Post-chemotherapy tumors in the PDX model identify ribosomal synthesis as a novel targeting strategy in ovarian cancer
157
Long term safety follow up, dosimetry and immunologic responses in patients enrolled on a phase I trial of intraperitoneal 212Pb labeled trastuzumab
199
Are hospital readmissions an accurate measure of quality cancer care in gynecologic oncology patients?
251
Comprehensive genetic testing: the next generation in an ovarian cancer risk assessment clinic
328
Utilizing camelid-derived single domain antibodies to enhance immunotherapy of ovarian cancer
426
Genetic counseling and evaluation of BRCA mutations in an African American female population in the Deep South